Get the Stockscreener App
0.2314
6.32%
-0.0156
After Hours:
.23
-0.0014
-0.61%
Applied Dna Sciences Inc stock is traded at $0.2314, with a volume of 8.21M.
It is down -6.32% in the last 24 hours and up +18.00% over the past month.
Applied DNA Sciences Inc is a biotechnology company developing and commercializing technologies to produce and detect deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). The company operates in three business segments- Therapeutic DNA Production Services, MDx Testing Services, and DNA Tagging and Security Products and Services. It generates majority of its revenue from the MDx Testing Services which is involved in performing and developing clinical molecular diagnostic and genetic tests and clinical laboratory testing services. The company provides its products and services under the brand of Applied DNA Sciences, SigNature molecular tags, SigNature T molecular tags, fiberTyping, SigNify and others.
See More
Previous Close:
$0.247
Open:
$0.2367
24h Volume:
8.21M
Relative Volume:
1.37
Market Cap:
$12.10M
Revenue:
$9.00M
Net Income/Loss:
$-7.21M
P/E Ratio:
-0.4207
EPS:
-0.55
Net Cash Flow:
$-7.59M
1W Performance:
+28.56%
1M Performance:
+18.00%
6M Performance:
-40.67%
1Y Performance:
-98.16%
1-Day Range:
$0.215
$0.2445
1-Week Range:
$0.175
$0.2544
52-Week Range:
$0.1204
$14.40
Applied Dna Sciences Inc Stock (APDN) Company Profile
Name
Applied Dna Sciences Inc
Sector
Industry
Phone
631-240-8800
Address
50 HEALTH SCIENCES DRIVE, STONY BROOK, NY
Compare APDN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
APDN
Applied Dna Sciences Inc
|
0.2314 | 12.10M | 9.00M | -7.21M | -7.59M | -0.55 |
|
TMO
Thermo Fisher Scientific Inc
|
532.02 | 203.50B | 42.37B | 6.14B | 7.78B | 15.95 |
|
DHR
Danaher Corp
|
234.84 | 169.62B | 23.74B | 3.89B | 4.98B | 5.24 |
|
A
Agilent Technologies Inc
|
135.69 | 38.75B | 6.51B | 1.29B | 1.37B | 4.42 |
|
IQV
Iqvia Holdings Inc
|
197.39 | 35.83B | 15.32B | 1.41B | 1.96B | 7.62 |
|
IDXX
Idexx Laboratories Inc
|
415.53 | 34.03B | 3.84B | 866.24M | 792.60M | 10.37 |
Applied Dna Sciences Inc Stock (APDN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-12-21 | Initiated | ROTH Capital | Buy |
| Jan-14-21 | Reiterated | H.C. Wainwright | Buy |
| Dec-18-20 | Reiterated | H.C. Wainwright | Buy |
| Jul-20-20 | Reiterated | H.C. Wainwright | Buy |
| Jul-02-20 | Initiated | H.C. Wainwright | Buy |
| Nov-14-16 | Reiterated | Maxim Group | Buy |
| May-13-16 | Reiterated | Maxim Group | Buy |
| Oct-08-15 | Reiterated | Maxim Group | Buy |
| May-26-15 | Initiated | The Benchmark Company | Speculative Buy |
| Feb-10-15 | Reiterated | Maxim Group | Buy |
| Jan-13-15 | Initiated | Maxim Group | Buy |
View All
Applied Dna Sciences Inc Stock (APDN) Latest News
SABBY MANAGEMENT, LLC Acquires Significant Stake in Applied DNA Sciences Inc - GuruFocus.com
Featured Company NewsApplied DNA Sciences Enters into CertainT Trademark License Agreement with Techmer PM - AccessWire
When Would Be The Best Time To Buy Applied Dna Sciences Inc (NASDAQ: APDN) Stock? - Stocks Register
Applied DNA Customer ÚHKT Initiates Phase I Clinical Trial for Rapidly Manufacturable CAR T-Cell Therapy Produced from Linea DNA - AccessWire
Applied DNA Sciences Secures Landmark Approval for Revolutionary CAR T-Cell Therapy Trial in Czech Republic - StockTitan
Why US Futures Are Rising WednesdayCorvus Pharma (NASDAQ:CRVS), Applied DNA Sciences (NASDAQ:APDN) - Benzinga
Why Corvus Pharmaceuticals Shares Are Trading Higher By Around 22%; Here Are 20 Stocks Moving Premarket - Benzinga
General Mills, Micron Technology And 3 Stocks To Watch Heading Into Wednesday - Benzinga
Applied DNA Sciences: Fiscal Q4 Earnings Snapshot - CT Insider
Applied DNA Sciences (APDN) Reports Q4 Loss, Tops Revenue Estimates - Yahoo Finance
Applied DNA Sciences Inc. (APDN) reports earnings - Quartz
Applied DNA Announces Fourth Quarter and Fiscal Year 2024 Financial Results, Announces Strategic Restructuring to Prioritize the Manufacture of Critical Starting Materials for Genetic Medicines - AccessWire
Applied DNA Sciences Pivots to Genetic Medicine Manufacturing, Plans Major Restructuring Amid Revenue Drop - StockTitan
Applied DNA to Report Fourth Quarter and Fiscal Year 2024 Financial Results After Market Close on December 17, 2024; Sets Webcast and Conference Call for January 9, 2025, to Coincide with Update on GMP Manufacturing Facility Build-out - AccessWire
Applied DNA Sciences Sets Q4 Earnings Date, to Update on Key Manufacturing Expansion - StockTitan
APDN stock plunges to 52-week low of $0.14 amid steep decline - Investing.com Australia
APDN stock plunges to 52-week low of $0.15 amid market challenges - Investing.com
Applied DNA Sciences, Inc. (NASDAQ:APDN) Sees Large Decrease in Short Interest - Defense World
Analysts Predict How High Applied Dna Sciences Inc (APDN) Will Go. - Stocks Register
Applied DNA stock jumps amid U.S. government mpox update - MSN
Anson Funds Management LP Acquires New Stake in Applied DNA Scie - GuruFocus.com
APDN stock plunges to 52-week low, touches $0.17 - Investing.com India
APDN stock plunges to 52-week low, touches $0.17 By Investing.com - Investing.com UK
Short Interest in Applied DNA Sciences, Inc. (NASDAQ:APDN) Declines By 28.4% - Defense World
Applied DNA faces Nasdaq delisting over share price By Investing.com - Investing.com UK
Applied DNA faces Nasdaq delisting over share price - Investing.com
Applied DNA Sciences Announces Pricing of $6.5 Million Registered Direct Offering and Concurrent Private Placement - Defense World
APDN stock plunges to 52-week low, touches $0.19 By Investing.com - Investing.com Australia
Applied DNA stock slides after pricing $6.5M securities offering - MSN
APDN stock plunges to 52-week low, touches $0.19 - Investing.com India
Applied DNA announces $6.5 million securities offering By Investing.com - Investing.com Canada
Applied DNA announces $6.5 million securities offering - Investing.com India
APDN Stock Earnings: Applied DNA Sciences Reported Results for Q3 2024 - MSN
Crude Oil Gains Over 2%; Eli Lilly Cuts 2024 Forecast - Benzinga
Applied DNA Announces Pricing of $6.5 Million Registered Direct Offering and Concurrent Private Placement - AccessWire
Applied DNA Sciences, Inc. announced that it expects to receive $6.5 million in funding - Marketscreener.com
It makes sense and dollars to buy Applied Dna Sciences Inc (APDN) stock - SETE News
Navigating APDN Stock: Applied Dna Sciences Inc Journey - The InvestChronicle
Applied DNA to Participate in the 2024 Maxim Healthcare Virtual Summit on Wednesday, October 16 - AccessWire
Did Applied Dna Sciences Inc (APDN) perform well in the last session? - US Post News
In the Green: Applied Dna Sciences Inc (APDN) Closes at 0.31, Up/Down -1.87 from Previous Day - The Dwinnex
Applied Dna Sciences Inc [APDN] is -97.40% lower this YTD. Is it still time to buy? - The DBT News
Choosing between riding the trend or protecting profits: Applied Dna Sciences Inc (APDN) - US Post News
Applied Dna Sciences Inc Stock (APDN) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.42%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):